Volume 50, Issue 12 pp. 4045-4050
Research Article

Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene

Juan I. Aróstegui

Corresponding Author

Juan I. Aróstegui

Hospital Clínic, Barcelona, Spain

Servicio de Inmunología, Hospital Clínic, Villarroel 170, 08036-Barcelona, SpainSearch for more papers by this author
Anna Aldea

Anna Aldea

Hospital Clínic, Barcelona, Spain

Search for more papers by this author
Consuelo Modesto

Consuelo Modesto

Hospital de la Vall d'Hebron, Barcelona, Spain

Search for more papers by this author
Maria Jesús Rua

Maria Jesús Rua

Hospital de Cruces, Baracaldo, Vizcaya, Spain

Search for more papers by this author
Federico Argüelles

Federico Argüelles

Hospital Virgen de la Macarena, Seville, Spain

Search for more papers by this author
Maria Antonia González-Enseñat

Maria Antonia González-Enseñat

Hospital Sant Joan de Deu, Esplugues, Barcelona, Spain

Search for more papers by this author
Eduardo Ramos

Eduardo Ramos

Hospital Central de Asturias, Oviedo, Spain

Search for more papers by this author
Josefa Rius

Josefa Rius

Hospital Clínic, Barcelona, Spain

Search for more papers by this author
Susana Plaza

Susana Plaza

Hospital Clínic, Barcelona, Spain

Search for more papers by this author
Jordi Vives

Jordi Vives

Hospital Clínic, Barcelona, Spain

Search for more papers by this author
Jordi Yagüe

Jordi Yagüe

Hospital Clínic, Barcelona, Spain

Search for more papers by this author
First published: 08 December 2004
Citations: 82

Abstract

Objective

To investigate the involvement of the CIAS1/PYPAF1/NALP3 gene in 7 unrelated Spanish families with recurrent autoinflammatory diseases characterized by early onset, recurrent fever, and a chronic urticarial rash, in whom a clinical diagnosis of cryopyrin-associated periodic syndromes (CAPS) is suspected.

Methods

Clinical symptoms, results of laboratory analyses, and data on previous treatments in members of the 7 families were recorded on a questionnaire specific for hereditary autoinflammatory diseases. All coding regions and intronic flanking boundaries of the CIAS1/PYPAF1/NALP3 gene were amplified by polymerase chain reaction and sequenced.

Results

Five different missense mutations, including 2 de novo and 1 previously unreported mutation (R488K), were identified in exon 3 of the CIAS1/PYPAF1/NALP3 gene in 5 of the 7 affected families. Expanded genetic analysis among the healthy individuals identified incomplete penetrance in 2 families. No mutations were found in 2 of the 3 patients with chronic infantile neurologic, cutaneous, articular (CINCA) syndrome/neonatal-onset multisystem inflammatory disease (NOMID).

Conclusion

The clinical data suggested a diagnosis of familial cold-induced autoinflammatory syndrome in 3 families, CINCA/NOMID syndrome in 3 others, and a possible Muckle-Wells syndrome, whereas mutational analysis showed different CIAS1/PYPAF1/NALP3 missense mutations in 5 families. These data are consistent with a common molecular basis of these diseases and highlights the phenotypic heterogeneity among CIAS1/PYPAF1/NALP3 gene–associated syndromes. The previously unreported mutation and the incomplete penetrance found in 2 families expand the genetic basis underlying these autoinflammatory syndromes. These findings should alert clinicians to the possible genetic basis of these conditions, even in the absence of a family history, in their attempts to establish an accurate diagnosis and the optimal therapeutic approach.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me